Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Inside-Out, Dual Light-, and pH-Triggered Release from Oil-Core Microcapsules Via CATCH Cleavage Mechanism.

ACS macro letters·2026
Same author

Real-time monitoring of the reversible capture and release of CO<sub>2</sub> on anthraquinone and riboflavin-modified graphitic electrodes using ATR-SEIRAS.

Chemical science·2025
Same author

Toward Polymeric Room Temperature Acid Generators.

ChemistryOpen·2024
Same author

End-of-life upcycling of polyurethanes using a room temperature, mechanism-based degradation.

Nature chemistry·2023
Same author

Selective and Reversible Ligand Assembly on the DNA and RNA Repeat Sequences in Myotonic Dystrophy.

Chembiochem : a European journal of chemical biology·2022
Same author

pH-Triggered Release from Polyamide Microcapsules Prepared by Interfacial Polymerization of a Simple Diester Monomer.

ACS macro letters·2022
Same journal

Charting New Territory: Systematic Evaluation of the Drug Potential of <i>N</i>-Trifluoromethyl Amides, Ureas & Carbamates.

Journal of medicinal chemistry·2026
Same journal

Red-Light-Triggered <i>In Vitro</i> and <i>In Vivo</i> Photocatalytic Cancer Therapy with Polypyridyl Os(II) Photocatalysts.

Journal of medicinal chemistry·2026
Same journal

Novel Selenium-Containing Small Molecule PD-L1 Inhibitors: Design, Synthesis, and Evaluation of the Antitumor Activity.

Journal of medicinal chemistry·2026
Same journal

HsClpP-Engaging Selective Mitochondrial Pan-PDK Degraders for Cancer Therapy.

Journal of medicinal chemistry·2026
Same journal

Rational Development of Activatable Prodrugs of the GSTP1 Inhibitor NBDHEX: Turn-On NIR Fluorogenic Drug Delivery with Selective Anticancer Activity.

Journal of medicinal chemistry·2026
Same journal

Recent Highlights in the Discovery and Design of Antibody-Drug Conjugates.

Journal of medicinal chemistry·2026
See all related articles

Related Experiment Video

Updated: Aug 29, 2025

Kinetic Screening of Nuclease Activity using Nucleic Acid Probes
06:52

Kinetic Screening of Nuclease Activity using Nucleic Acid Probes

Published on: November 1, 2019

8.4K

Dynamic Covalent Template-Guided Screen for Nucleic Acid-Targeting Agents.

Sarah B Krueger1, Steven C Zimmerman1

  • 1Department of Chemistry, University of Illinois at Urbana-Champaign, Urbana, Illinois 61801, United States.

Journal of Medicinal Chemistry
|September 13, 2022
PubMed
Summary
This summary is machine-generated.

Researchers developed a novel screening method using dynamic covalent chemistry to create targeted inhibitors for trinucleotide repeat diseases like myotonic dystrophy type 1 (DM1) and Huntington's disease (HD). This approach successfully identified compounds that selectively inhibit transcription in these genetic disorders.

More Related Videos

Covalent Fragment Screening Using the Quantitative Irreversible Tethering Assay
06:17

Covalent Fragment Screening Using the Quantitative Irreversible Tethering Assay

Published on: February 28, 2025

662
Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery
06:26

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery

Published on: May 16, 2021

5.0K

Related Experiment Videos

Last Updated: Aug 29, 2025

Kinetic Screening of Nuclease Activity using Nucleic Acid Probes
06:52

Kinetic Screening of Nuclease Activity using Nucleic Acid Probes

Published on: November 1, 2019

8.4K
Covalent Fragment Screening Using the Quantitative Irreversible Tethering Assay
06:17

Covalent Fragment Screening Using the Quantitative Irreversible Tethering Assay

Published on: February 28, 2025

662
Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery
06:26

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery

Published on: May 16, 2021

5.0K

Area of Science:

  • Molecular Biology
  • Medicinal Chemistry
  • Genetics

Background:

  • Trinucleotide repeat diseases, including myotonic dystrophy type 1 (DM1) and Huntington's disease (HD), are caused by expanded DNA repeats.
  • These expanded repeats can serve as templates for synthesizing specific inhibitors.
  • Developing agents that can reversibly assemble in situ to target multiple nucleic acids is highly desirable.

Purpose of the Study:

  • To develop a target-guided screening approach utilizing dynamic covalent chemistry.
  • To identify multitarget inhibitors for trinucleotide repeat diseases.
  • To synthesize and evaluate amine- or aldehyde-containing fragments for inhibitor development.

Main Methods:

  • Synthesis of a diverse library of amine- and aldehyde-containing chemical fragments.
  • Target-guided screening employing dynamic covalent chemistry for fragment assembly.
  • Confirmation of hit combinations using matrix-assisted laser desorption/ionization-mass spectrometry (MALDI-MS) with DM1 and HD repeat sequences.
  • In vitro assessment of transcriptional inhibition and cooperativity.

Main Results:

  • A diverse set of hit combinations was successfully assembled from the fragment library.
  • Hit combinations were confirmed to bind to DM1 and HD repeat sequences via MALDI-MS.
  • The identified compounds selectively inhibited transcription in a cooperative manner in vitro.
  • Inhibitory concentration (IC50) values for the hit compounds were in the micromolar range.

Conclusions:

  • The dynamic covalent library and screening approach is effective for identifying inhibitors of trinucleotide repeat sequences.
  • This method successfully yielded compounds that selectively and cooperatively inhibit transcription in vitro.
  • The strategy holds potential for developing reversible, multivalent nucleic acid-targeting agents for various diseases.